CLOVER HEALTH (CLOV) Interim CFO Joseph Thornton Receives RSU Award

What Happened

• Joseph Clay Thornton, Interim Chief Financial Officer of Clover Health (CLOV), received an award of 54,347 restricted stock units (RSUs) on August 12, 2026. The RSUs were granted at $0.00 (no cash paid at grant) and are reported as an "A" (award/grant) transaction on the Form 4.

Key Details

• Transaction date: August 12, 2026; reported on Form 4 filed August 13, 2026 (timely).
• Award: 54,347 RSUs underlying Class A common stock; grant price: $0.00.
• Shares owned after transaction: Not specified in the reported filing.
• Vesting (per footnote): 25% vests on Aug 12, 2027; remaining RSUs vest in 12 equal quarterly installments beginning three months after that date; fully vested Aug 12, 2030, subject to continued service.
• No 10b5-1 plan, tax-withholding detail, or cashless sale reported in this filing.

Context

• RSUs are a form of equity compensation that convert into actual shares only when they vest; this grant does not represent an immediate open-market purchase or sale. Such awards are common for executive compensation and do not by themselves indicate a short-term trading signal.